Recura AI Inc.

Recura AI Inc. , based in the US, develops innovative software solutions that leverage artificial intelligence to optimize sales processes and enhance customer engagement for medical clinics. Recura AI Inc. specializes in AI-driven software designed for healthcare providers, particularly medical clinics.

Founded in 2024, the company has engaged in its first deal, indicating a strategic focus on growth. The company is headquartered in the United States. Recura was acquired by PatientNOW, Inc. in October 2025, a move aimed at accelerating growth and enhancing software solutions, with financial details undisclosed.

Recura offers a comprehensive suite of AI-driven tools designed to enhance sales and customer engagement processes for medical clinics. Their core product is an AI-powered sales platform that automates follow-up communications, enabling clinics to engage potential leads through calls and texts promptly. By integrating deeply with electronic medical records (EMR) systems, Recura provides clinics with real-time availability and detailed service information, facilitating seamless appointment bookings. Their solutions cater to clinics across various sectors, including aesthetics, dermatology, and general medical practices, focusing on improving patient experiences and clinic growth.

Recura primarily targets multi-location clinics and those with 1-5 staff members, serving clients in the United States and Canada. Recura operates on a subscription-based revenue model, allowing clinics to access their AI-powered sales and marketing services. This model accommodates various clinic sizes and includes features such as automated lead responses, follow-up campaigns, and performance analytics. Clinics can subscribe to specific service tiers based on their operational needs, which may vary in price according to the functionalities selected.

For example, packages might include an AI sales director and a 24/7 patient coordinator, enhancing patient engagement during and after business hours. Revenue is generated through these structured subscriptions, ensuring ongoing access to Recura's technology and support services. In October 2025, Recura AI Inc. was acquired by PatientNOW, Inc.

, which plans to leverage this acquisition to accelerate its growth and enhance its software solutions. The acquisition supports Recura's strategy for expansion and product development, although specific details regarding upcoming products or market entries have not been disclosed. The recent funding will be utilized to bolster these initiatives, focusing on refining their offerings and potentially exploring new geographic markets. Recura will continue to operate as a standalone business, continuing to sell directly to non-PatientNow customers, focusing on delivering industry-leading growth solutions, as well as powering innovation for PatientNow and supporting its existing customers and both new and existing integrations.